Maze Therapeutics, Inc.

MAZE Stock Healthcare Biotechnology
$27.53
+0.05 (+0.18%)
Price as of Oct 16, 2026 market close

Performance

1 Month
+17.4%
3 Months
-3.0%
YTD
-33.6%
1 Year
-5.9%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
66.9%
Largest decline max drawdown, since Jan 2025
-56.8%
Risk-adjusted return Sharpe ratio, 1-year
0.26

Own MAZE?

See how MAZE contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.